Analysis

With billions of dollars in market value, the psychedelic drug industry has exploded over the past year. Starting in March of 2020, with the listing of MindMed on Canada’s Neo Exchange, there are now over 50 publicly traded companies focusing on psychedelics.  This comes as quite a surprise to new investors discovering the growing psychedelics […]

Ketamine is an emerging sector of the psychedelic medicine industry. With ketamine-assisted therapy recently being designated as a “breakthrough therapy” by the FDA, there’s been a massive amount of interest in the drug from investors and medical professionals alike. Learn more about all the new medications, treatment centers, clinical trials, and ways to gain exposure […]

Explaining a psychedelic trip is nearly impossible. Authors, song writers, and filmmakers have tried for years to explain what the whole experience is like, but always fall just short.  However, despite the difficulty to explain what a psychedelic experience is like, there is one thing that nearly everyone agrees on: A psychedelic experience shows how […]

Defiance ETFs filed a Registration Statement with the SEC on March 5th, 2021, for a “Next Gen Altered Experience ETF.”